| Luke Smith, LICSW | |
|
515 Moscow Rd, Stowe, VT 05672-5113 | |
| (802) 696-8900 | |
| Not Available |
| Full Name | Luke Smith |
|---|---|
| Gender | Male |
| Speciality | Clinical Social Worker |
| Experience | 11 Years |
| Location | 515 Moscow Rd, Stowe, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922463652 | NPI | - | NPPES |
| 1026190 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 089.0111500 (Vermont) | Primary |
| Entity Name | Hear Today Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861977621 PECOS PAC ID: 3577808831 Enrollment ID: O20181214002437 |
News Archive
A soft, extendible band fitted around the chest may help to relieve cough in patients with persistent dry cough. Over the course of 1 year, Japanese researchers evaluated the antitussive effect of the chest band worn for 8 hours a day in 56 patients with chronic cough due to a variety of conditions.
Boston Scientific Corporation reports positive results from a pre-specified analysis of the first 60 patients enrolled in the REPRISE II trial evaluating the performance and safety of the Lotus™ Valve System in symptomatic patients with severe aortic valve disease considered at high risk for surgical valve replacement.
Ascendancy Healthcare, Inc. dedicated to the commercialization of therapeutic products to meet unmet medical needs in China and other high-growth Asian markets, announced today a multi-year collaboration with Quintiles, the world's largest provider of biopharmaceutical development and commercial outsourcing services.
Researchers at Rice University have won federal support to develop a genomic test that can quickly determine whether a disease outbreak is caused by a natural pathogen or one that was grown in a lab by terrorists.
Research by investigators at The Cancer Institute of New Jersey (CINJ) is showing new promise in the treatment of melanoma, the most serious of skin cancers. The findings, published in the May 27, 2010, online edition of the Journal of Investigative Dermatology further validate the team's clinical and pre-clinical findings that blocking the signaling normally activated by a receptor called Grm1 results in decreased cell growth and decreased migration of melanoma cells, confirming that Grm1 is a potential target for the treatment of melanoma.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Luke Smith, LICSW Po Box 1232, Stowe, VT 05672-1232 Ph: (802) 696-8900 | Luke Smith, LICSW 515 Moscow Rd, Stowe, VT 05672-5113 Ph: (802) 696-8900 |
News Archive
A soft, extendible band fitted around the chest may help to relieve cough in patients with persistent dry cough. Over the course of 1 year, Japanese researchers evaluated the antitussive effect of the chest band worn for 8 hours a day in 56 patients with chronic cough due to a variety of conditions.
Boston Scientific Corporation reports positive results from a pre-specified analysis of the first 60 patients enrolled in the REPRISE II trial evaluating the performance and safety of the Lotus™ Valve System in symptomatic patients with severe aortic valve disease considered at high risk for surgical valve replacement.
Ascendancy Healthcare, Inc. dedicated to the commercialization of therapeutic products to meet unmet medical needs in China and other high-growth Asian markets, announced today a multi-year collaboration with Quintiles, the world's largest provider of biopharmaceutical development and commercial outsourcing services.
Researchers at Rice University have won federal support to develop a genomic test that can quickly determine whether a disease outbreak is caused by a natural pathogen or one that was grown in a lab by terrorists.
Research by investigators at The Cancer Institute of New Jersey (CINJ) is showing new promise in the treatment of melanoma, the most serious of skin cancers. The findings, published in the May 27, 2010, online edition of the Journal of Investigative Dermatology further validate the team's clinical and pre-clinical findings that blocking the signaling normally activated by a receptor called Grm1 results in decreased cell growth and decreased migration of melanoma cells, confirming that Grm1 is a potential target for the treatment of melanoma.
› Verified 1 days ago
Sean Ryan, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 56 Old Farm Rd, Stowe, VT 05672 Phone: 802-433-4134 | |
Holly D Ryan, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 56 Old Farm Rd, Stowe, VT 05672 Phone: 802-760-7497 | |
Dawn A Palladino, LICSW, LADC Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 56 Old Farm Rd, Stowe, VT 05672 Phone: 802-249-1022 |